This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)(Learn how and when to remove this template message)
Photoaging or photoageing (also known as "dermatoheliosis") is a term used for the characteristic changes to skin induced by chronic UVA and UVB exposure.:29 Tretinoin is the best studied retinoid in the treatment of photoaging
The deterioration of biological functions and ability to manage metabolic stress is one of the major consequences of the aging process. Aging is a complex, progressive process that leads to functional and esthetic changes in the skin. This process can result from both intrinsic (i.e., genetically determined) as well as extrinsic processes (i.e., environmental factors). Photoaging is attributed to continuous, long-term exposure to ultraviolet (UV) radiation of approximately 300–400 nm, either natural or synthetic, on an intrinsically aged skin.
- 1 Effects of UV light
- 2 Signs, symptoms and histopathology
- 3 Defense Mechanisms
- 4 Treatment
- 5 See also
- 6 References
- 7 External links
Effects of UV light
Molecular and genetic changes
UVB rays are a primary mutagen that can only penetrate through the epidermal (outermost) layer of the skin, resulting in DNA mutations. These mutations arise due to chemical changes, the formation of cyclobutane pyrimidine dimers and photoproducts formed between adjacent pyrimidine bases. These mutations may be clinically related to specific signs of photoaging such as wrinkling, increasing in elastin and collagen damage.
The epidermal layer does not contain any blood vessels or nerve endings but melanocytes and basal cells are embedded in this layer. Upon exposure to UVB rays, melanocytes will produce melanin, a pigment that gives the skin its color tone. However, UVB will cause the formation of freckles and dark spots, both of which are symptoms of photoaging. With constant exposure to UVB rays, signs of photoaging might appear and precancerous lesions or skin cancer may develop.
UVA rays are able to penetrate deeper into the skin as compared to UVB rays. Hence, in addition to the epidermal layer, the dermal layer will also be damaged. The dermis is the second major layer of the skin and it comprises collagen, elastin, and extrafibrillar matrix which provides structural support to the skin. However, with constant UVA exposure, the size of the dermis layer will be reduced, thereby causing the epidermis to start drooping off the body. Due to the presence of blood vessels in the dermis, UVA rays can lead to dilated or broken blood vessels which are most commonly visible on the nose and cheeks. UVA can also damage DNA indirectly through the generation of reactive oxygen species (ROS), which include superoxide anion, peroxide and singlet oxygen. These ROS damage cellular DNA as well as lipids and proteins.
UV exposure can also lead to inflammation and vasodilation which is clinically manifested as sunburn. UV radiation activates the transcription factor, NF-κB, which is the first step in inflammation. NF-κB activation results in the increase of proinflammatory cytokines, for example: interleukin 1 (IL-1), IL-6 vascular endothelial growth factor, and tumor necrosis factor (TNF-α). This then attract neutrophils which lead to an increase in oxidative damage through the generation of free radicals.
Additionally, UV radiation would cause the down-regulation of an angiogenesis inhibitor, thrombospondin-1, and the up-regulation of an angiogenesis activator which is platelet-derived endothelial cell growth factor, in keratinocytes. These enhance angiogenesis and aid in the growth of UV-induced neoplasms.
It has been reported that UV radiation leads to local and systemic immunosuppression, due to DNA damage and altered cytokine expression. This has implications in cutaneous tumor surveillance. The Langerhans cells may undergo changes in quantity, morphology, and function due to UV exposure and may eventually become depleted. One proposed explanation for this immunosuppression is that the body is attempting to suppress an autoimmune response to inflammatory products resulting from UV damage.
Degradation of collagen
UV exposure would also lead to the activation of receptors for epidermal growth factor, IL-1, and TNF-α in keratinocytes and fibroblasts, which then activates signaling kinases throughout the skin via an unknown mechanism. The nuclear transcription factor activator protein, AP-1, which controls the transcription of matrix metalloproteinases (MMP), is expressed and activated. MMP-1 is a major metalloproteinases for collagen degradation. This entire process is aided by the presence of reactive oxygen species that inhibits protein-tyrosine phosphatases via oxidation, thereby resulting in the up-regulation of the above-mentioned receptors. Another transcription factor NF-κB, which is also activated by UV light, also increases the expression of MMP-9.
The up-regulation of MMP can occur even after minimal exposure to UV, hence, exposure to UV radiation which is inadequate to cause sunburn can thus facilitate the degradation of skin collagen and lead to presumably, eventual photoaging. Thus, collagen production is reduced in photoaged skin due to the process of constant degradation of collagen mediated by MMPs.
In addition, the presence of damaged collagen would also down-regulate the synthesis of new collagen. The impaired spreading and attachment of fibroblasts onto degraded collagen could be one of the contributing factors to the inhibition of collagen synthesis.
Retinoic acids and photodamage
UV radiation decreases the expression of both retinoic acid receptors and retinoid X receptors in human skin, thereby resulting in a complete loss of the induction of RA-responsive genes. It also leads to an increase in activity of the AP-1 pathway, increasing MMP activity and thus resulting in a functional deficiency of vitamin A in the skin.
Signs, symptoms and histopathology
Early symptoms of photoaging:
- Dyspigmentation, the formation of wrinkles and other symptoms appear around regions of skin commonly exposed to sun, mostly the eyes, mouth and forehead. The lips may be affected. In Canadian women, the upper chest is commonly affected.
- Spider veins on face and neck
- Loss of color and fullness in lips
Symptoms of photoaging attributed to prolonged exposure to UV:
- Wrinkles deepen and forehead frown lines can be seen even when not frowning.
- Telangiectasias (spider veins) most commonly seen around the nose, cheeks and chin.
- Skin becomes leathery and laxity occurs.
- Solar lentigines (age spots) appear on the face and hands.
- Possibly pre-cancerous red and scaly spots (actinic keratoses) appear.
- Cutaneous malignancies
In addition to the above symptoms, photoaging can also result in an orderly maturation of keratinocytes and an increase in the cell population of the dermis where abundant; hyperplastic, elongated and collapsed fibroblasts and inflammatory infiltrates are found.
Photodamage can also be characterized as a disorganization of the collagen fibrils that constitute most of the connective tissue, and the accumulation of abnormal, amorphous, elastin-containing material, a condition known as actinic elastosis.
Endogenous defense mechanisms provide protection of the skin from damages induced by UV.
UV exposure which would lead to an increase in epidermal thickness could help protect from further UV damage.
It has been reported in many cases that fairer individuals who have lesser melanin pigment show more dermal DNA photodamage, infiltrating neutrophils, keratinocyte activation, IL-10 expression and increased MMPs after UV exposure. Therefore, the distribution of melanin provides protection from sunburn, photoaging, and carcinogenesis by absorbing and scattering UV rays.
Repair of DNA mutation and apoptosis
The damage of DNA due to exposure of UV rays will lead to expression of p53, thereby leading to eventual arrest of the cell cycle. This allows DNA repair mediated by endogenous mechanisms like the nucleotide excision repair system. In addition, apoptosis occurs if the damage is too severe. However, the apoptotic mechanisms decline with age, and if neither DNA repair mechanism nor apoptosis occurs, cutaneous tumorigenesis may result.
Tissue inhibitors of MMPs (TIMPs)
TIMPs regulate the activity of MMP. Many studies have shown that UV rays would induce TIMP-1.
The skin contains several antioxidants, including vitamin E, coenzyme Q10, ascorbate, carotenoids, superoxide dismutase, catalase, and glutathione peroxidase. These antioxidants provide protection from reactive oxygen species produced during normal cellular metabolism. However, overexposure to UV rays can lead to a significant reduction in the antioxidant supply, thus increasing oxidative stress. Hence, these antioxidants are essential in the skin's defense mechanism against UV radiation and photocarcinogenesis.
Treatment and intervention for photoaging can be classified into a unique paradigm based on disease prevention.
Primary prevention aims to reduce the risk factors before a disease or condition occurs.
Sun protection is the most effective form of primary prevention of photoaging. The major methods of sun protection are sunscreen products, sun protective clothing, and reducing exposure to the sun, especially during peak sun hours (10 AM-4PM in the spring and summer seasons). Broad-spectrum sunscreen products provide optimal coverage for protection against UV damage because they protect against both types of UVA rays (UVA1 and UVA2) along with UVB rays. Proper application methods and timing are important factors in proper sunscreen use. This includes using a proper quantity of sunscreen, applying sunscreen prior to sun exposure, and consistent reapplication (especially after exposure to water or sweat).
Secondary protection refers to early detection of disease, potentially while still asymptomatic, to allow positive interference to prevent, delay, or attenuate the symptomatic clinical condition. This includes the following: retinoids (e.g. tretinoin), antioxidants (e.g. topical vitamin C, oral supplements, CoQ10, Lipoic acid), estrogens, growth factors and cytokines.
There are various forms of topical retinoids. Tretinoin, a retinoid, is widely considered to be the most efficacious treatment for photoaging by dermatologists due to consistent evidence from several randomized clinical trials. Retinoids are vitamin A derivatives that bind to retinoic acid receptors (RARs) and retinoid X receptors (RXRs). Binding to these receptors induces a cascade of cellular processes that ultimately lead to increased collagen production and epidermal thickening, reducing the appearance of skin sagging and wrinkling. Tretinoin is also efficacious for the treatment of acne. Adapalene and tazarotene are also third-generation synthetic retinoids that are used for the treatment for acne. Adapalene has not been widely studied or proven for use in photoaging. However, it has been used off-label for that purpose. Tazarotene is been proven to be efficiacious in the treatment of photoaging. Retinoid derivatives, known as retinol and retinal, are often used in over the counter cosmeceutical products for anti-aging purposes. The form of retinol and retinal are metabolized in the skin to retinoic acid, which can then act on the RARs and RXRs. These products are considered cosmeceuticals rather than drugs due to their lack of regulation, and they have not been widely studied. Furthermore, tretinoin is the most well studied and consistent in its efficacy in the treatment of photoaging.
Lastly, tertiary prevention is the treatment of an existing symptomatic disease process to ameliorate its effects or delay its progress. Such tertiary prevention includes the use of chemical peels, resurfacing techniques (e.g. micro-dermabrasion), ablative or non-ablative laser resurfacing, radio-frequency technology, soft tissue augmentation (also known as fillers), and botulinum toxins. Photorejuvenation procedures are performed by dermatologists to reduce the visible symptoms. Each of these treatment modalities have primary concerns that they address. For example, botulinum injections paralyze facial muscles. This prevents muscle contraction and subsequent wrinkle formation. Injectable fillers are often used in the nasolabial fold to increase volume and minimize the appearance of sagging or wrinkling.
- Helfrich, Y. S.; Sachs, D. L.; Voorhees, J. J. (Jun 2008). "Overview of skin aging and photoaging" (PDF). Dermatology nursing / Dermatology Nurses' Association. 20 (3): 177–183, quiz 183. ISSN 1060-3441. PMID 18649702.[permanent dead link]
- Rapini, Ronald P.; Bolognia, Jean L.; Jorizzo, Joseph L. (2007). Dermatology: 2-Volume Set. St. Louis: Mosby. ISBN 1-4160-2999-0.
- James, William D.; Berger, Timothy G. (2006). Andrews' Diseases of the Skin: clinical Dermatology. Saunders Elsevier. ISBN 0-7216-2921-0.
- Stefanaki, C.; Stratigos, A.; Katsambas, A. (2005). "Topical retinoids in the treatment of photoaging". Journal of Cosmetic Dermatology. 4 (2): 130–134. doi:10.1111/j.1473-2165.2005.40215.x. PMID 17166212.
- Spiekstra, SW; Breetveld; Rustemeyer; Scheper; Gibbs (September 2007). "Wound-healing factors secreted by epidermal keratinocytes and dermal fibroblasts in skin substitutes". Wound Repair and Regeneration. 15 (5): 708–17. doi:10.1111/j.1524-475X.2007.00280.x. PMID 17971017.
The secretion of proinflammatory cytokines (IL-1alpha, TNF-alpha), chemokine/mitogen (CCL5) and angiogenic factor (vascular endothelial growth factor) by epidermal substitutes and tissue remodeling factors (tissue inhibitor of metalloproteinase-2, hepatocyte growth factor) by dermal substitutes was not influenced by keratinocyte-fibroblast interactions. The full-skin substitute has a greater potential to stimulate wound healing than epidermal or dermal substitutes. Both epidermal-derived IL-1alpha and TNF-alpha are required to trigger the release of dermal-derived inflammatory/angiogenic mediators from skin substitutes.
- "Photoaging". Canadian Dermatology Association. Canadian Dermatology Association. Retrieved 14 May 2018.
- "UpToDate". www.uptodate.com. Retrieved 2018-04-14.
- Cosmetic dermatology. Alam, Murad., Gladstone, Hayes B., Tung, Rebecca C. Edinburgh: Saunders. 2009. ISBN 0702031437. OCLC 771939884.
- Stefanaki, Christina (August 3, 2005). "Topical Retinoids in the Treatment of Photoaging". Journal of Cosmetic Dermatology. 4: 130–134.
- Trivisonno, A.; Rossi, A.; Monti, M.; Di Nunno, D.; Desouches, C.; Cannistra, C.; Toietta, G. (2017). "Facial skin rejuvenation by autologous dermal microfat transfer in photoaged patients: Clinical evaluation and skin surface digital profilometry analysis". Journal of Plastic, Reconstructive & Aesthetic Surgery. 70 (8): 1118–1128. doi:10.1016/j.bjps.2017.04.002. PMID 28526633.
- "UpToDate". www.uptodate.com. Retrieved 2018-04-14.